Simultaneous Determination of Valproic Acid and its Toxic Metabolites, 4-ene-VPA and 2,4-diene-VPA in Rat Plasma using a Gas Chromatographic-mass Spectrometric Method |
Lee, Min-Sun
(Integrated Omics Center, Korea Institute of Science and Technology)
Lee, Young-Joo (College of Pharmacy, Kyung Hee University) Chung, Bong-Chul (Integrated Omics Center, Korea Institute of Science and Technology) Jung, Byung-Hwa (Integrated Omics Center, Korea Institute of Science and Technology) |
1 | Leis, H.J., Windischhofer, W., Rechberger, G.N., Fauler, G., 2003. Synthesis of [] valproic acid and its use as an internal standard for the quantitative measurement by gas chromatographyelectron ionization mass spectrometry, J. Chromatogr. B. 784, 69-75. DOI |
2 | Loscher, W., Nau, H., Wahnschaffe, U., Hönack , D., Rundfeldt, C., Wittfoht, W., Bojic U., 1993. Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. II. Influence of phenobarbital comedication, Epilepsy Res. 15, 113-131. DOI |
3 | Murakami, K., Sugimoto, T., Nishida, N., Kobayashi , Y., Kuhara, T., Matsumoto, I., 1992. Abnormal metabolism of carnitine and valproate in a case of acute encephalopathy during chronic valproate therapy, Brain Dev. 14, 178-181. DOI ScienceOn |
4 | Perucca, E., 2002. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience, CNS Drugs, 16, 695-714. DOI |
5 | Sugimoto, T., Nishida, N., Yasuhara, A., Ono A., Sakane, Y., Matsumura, T., 1983. Reye-like syndrome associated with valproic acid, Brain Dev. 5, 334-337. DOI ScienceOn |
6 | Yu, D., Gordon, J.D., Zheng, J., Panesar, S.K., Riggs, K.W., Rurak D.W., Abott, F.S., 1995. Determination of valproic acid and its metabolites using gas chromatography with mass selective detection: application to serum and urine samples from sheep, J. Chromatogr. B. 666, 269-281. DOI |
7 | Zafrani, E.S., Berthelot, P., 1982. Sodium valproate in the induction of unusual hepatotoxicity, Hepatology. 2, 648-649. DOI |
8 | Zimmerman, H.J., Ishak, K.G., 1982. Valproate-induced hepatic injury: analyses of 23 fatal cases, Hepatology. 2, 591-597. DOI |
9 | Bryant, A.E., Dreifuss, F.E., 1996. Valproic acid hepatic fatalities. III. U.S. experience since 1986, Neurology. 46, 465-469. DOI |
10 | Cheng, H., Liu, Z., Blum, W., Byrd, J.C., Klisovic, R., Grever, M.R., Marcucci, G., Chan, K.K., 2007. Quantification of valproic acid and its metabolite 2-propyl-4-pentenoic acid in human plasma using HPLC-MS/MS, J. Chromatogr. B., 850, 206-212. DOI |
11 | Fisher, E., Wittfohy, W., Nau, H., 1992. Quantitative determination of valproic acid and 14 metabolites in serum and urine by gas chromatography/mass spectrometry, Biomed. Chromatogr. 6, 24-9. DOI |
12 | Gerber, N., Dickinson, R.G., Harland, R.K., Lynn, R., Houghton, D. L., Antonias, J. I., Schimschock, J.C., 1979. Reye-like syndrome associated with valproic acid therapy, J. Pediatr. 95, 142-144. DOI |
13 | Kassahun, K., Farrell, K., Abott, F.S., 1991. Identification and characterization of the glutathione and N-acetylcysteine conjugates of (E)-2-propyl-2,4-pentadienoic acid, a toxic metabolite of valproic acid, in rats and humans, Drug. Metab. Dispos. 525-535. |